Jin Zhu

Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation — Positive Advanced Non–Small Cell Lung Cancer (CheckMate 370)

David R. Spigel, Craig H. Reynolds, David Waterhouse et al. · Journal of Thoracic Oncology · 2018 · 223 citations

Phase 1/2, Medicine, Immunology +9

Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial

Jeremy Sokolove, Michael Schiff, Roy Fleischmann et al. · Annals of the Rheumatic Diseases · 2015 · 181 citations · Full text

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

Huilin Zhang, Jinrong Qiu, Chunping Ye et al. · Scientific Reports · 2014 · 111 citations · Full text

Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer

Hong Lin, Jianfei Huang, Jinrong Qiu et al. · Experimental and Molecular Pathology · 2012 · 104 citations

Cyclin D1 Correlate, Upregulated Tacstd2, Oncology +10

Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis

Yu He, Xiangde Liu, Zhiyu Chen et al. · Clinical Cancer Research · 2007 · 99 citations